External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche at

WCN 2024

-
Coming soon
08:45 PM
Duration 1hr Buenos Aires, Argentina
IMAGINATION: A Global Phase 3 Trial of RO7434656, an Antisense Oligonucleotide Inhibitor of Complement Factor B, in IgA Nephropathy
Barratt J, Flöge J, Duggal V, Schmit N, Cheng J, Lo J, Rovin BH

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar